title: Not for the faint of heart. Boston Scientific's stent recall is a blow to earnings--but an opportunity for investors.
authors.forename: John
authors.initials: J
authors.lastname: Simons
mesh_terms: D001900:Boston; D003132:Commerce / Q000191:economics*; D006801:Humans; D007182:Income; D015607:Stents; D014481:United States